A case of mistaken identity: Saksenaea vasiformis of the orbit

ABSTRACT The authors describe a rare presentation of invasive fungal rhino-orbital cellulitis caused by Saksenaea vasiformis in an immunocompetent child. The patient was initially diagnosed and treated as Mucoraceae, which has a high mortality rate and is primarily seen in immunocompromised patients. Though of the same order, Mucorales, the families Mucoraceae and Saksenaeacae, may be difficult to differentiate on histologic examination and must be distinguished by fungal culture and speciation. Our patient responded well to sino-orbital debridement and systemic treatment with amphotericin and posaconazole.

[1]  S. Lockhart,et al.  Saksenaea vasiformis Orbital Cellulitis in an Immunocompetent Child Treated With Posaconazole , 2018, Journal of the Pediatric Infectious Diseases Society.

[2]  M. Vagefi,et al.  Retrobulbar Injection of Amphotericin B for Orbital Mucormycosis. , 2017, Ophthalmic plastic and reconstructive surgery.

[3]  D. Hennessey,et al.  Saksenaea vasiformis infection in an immunocompetent patient in rural Australia , 2017, BMJ Case Reports.

[4]  Z. Joos,et al.  Intraorbital Irrigation of Amphotericin B in the Treatment of Rhino-Orbital Mucormycosis. , 2017, Ophthalmic plastic and reconstructive surgery.

[5]  Frank Brodie,et al.  Orbital compartment syndrome following retrobulbar injection of amphotericin B for invasive fungal disease , 2016, American journal of ophthalmology case reports.

[6]  Michael J. Richard,et al.  The Role of Adjunctive Therapies in the Management of Invasive Sino-Orbital Infection , 2015, Ophthalmic plastic and reconstructive surgery.

[7]  R. McLemore,et al.  Liposomal Formulation Decreases Toxicity of Amphotericin B In Vitro and In Vivo , 2015, Clinical orthopaedics and related research.

[8]  J. Turner,et al.  Survival outcomes in acute invasive fungal sinusitis: A systematic review and quantitative synthesis of published evidence , 2013, The Laryngoscope.

[9]  J. Guarro,et al.  Rare pediatric rhino-orbital infection caused by Saksenaea vasiformis , 2012, Infection.

[10]  D. R. Jordan,et al.  Orbital Apergillosis Treated with Retrobulbar Amphotericin B , 2012, Orbit.

[11]  R. McLemore,et al.  Amphotericin B Is Cytotoxic at Locally Delivered Concentrations , 2011, Clinical orthopaedics and related research.

[12]  Russell E. Lewis,et al.  Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species , 2011, Clinical Microbiology Reviews.

[13]  J. Guarro,et al.  Spectrum of Zygomycete Species Identified in Clinically Significant Specimens in the United States , 2009, Journal of Clinical Microbiology.

[14]  T. Wakabayashi,et al.  Retrobulbar Amphotericin B Injections for Treatment of Invasive Sino-orbital Aspergillosis , 2007, Japanese Journal of Ophthalmology.

[15]  J. Guarro,et al.  Saksenaea vasiformis infections: Case report and literature review , 2006, Mycopathologia.

[16]  R. Bentley,et al.  Normal changes in orbital volume during childhood. , 2002, Journal of neurosurgery.

[17]  S. Seiff,et al.  Role of local amphotericin B therapy for sino-orbital fungal infections. , 1999, Ophthalmic plastic and reconstructive surgery.

[18]  B. Guglielmo,et al.  Lipid formulations of amphotericin B: clinical efficacy and toxicities. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  S. Koletar,et al.  Intraorbital Injection of Amphotericin B for Palliative Treatment of Aspergillus Orbital Abscess , 1994, Ophthalmic plastic and reconstructive surgery.

[20]  D. Dean,et al.  The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis. , 1976, Mycologia.